In model 1, the risk of MS increased in the ALT level ranges of 10–20 and 20–40 U/L compared with that in ALT <10 U/L, respectively (aOR, 2.20 [95% CI, 1.90–2.55]; aOR, 5.28 [95% CI, 4.53–6.15]). This evidence concerns the gene GPT and myeloid sarcoma.